But a defense attorney for the device manufacturer, Lori Cohen, told that jury that Cisson's health problems dated back to the 1980s and that she had actually seen improvement.
Cohen said the success rate with transvaginal mesh was 97 percent, and the plastic in the product was a common component of many medical devices.
A new jury was seated for a new trial Monday, and attorneys presented their opening statements. Witnesses are expected to take the stand today.
Goodwin will make decisions after the verdicts in Cisson's trial -- and three more that will follow -- that will affect how the rest of the mesh cases against six manufacturers will be handled.
The pelvic repair device cases are not a class action lawsuit but have been combined under what is termed multi-district litigation in an effort to streamline them. All have been assigned by a panel to Goodwin.
In the past, the same judge has presided over multi-district litigation involving the drugs Digitek and Serzone.
Contact writer Cheryl Caswell at cher...@dailymail.com or 304-348-4832.
Other Cops and Courts HeadlinesOne teen dead, four injured in eastern Kanawha car crash